These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12414339)

  • 1. Combining better quality of life with reduced costs in patients with multiple myeloma.
    Haematologica; 2002 Nov; 87(11):1125. PubMed ID: 12414339
    [No Abstract]   [Full Text] [Related]  

  • 2. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
    Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
    Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom burden in patients undergoing autologous stem-cell transplantation.
    Anderson KO; Giralt SA; Mendoza TR; Brown JO; Neumann JL; Mobley GM; Wang XS; Cleeland CS
    Bone Marrow Transplant; 2007 Jun; 39(12):759-66. PubMed ID: 17438588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation.
    Sherman AC; Simonton S; Latif U; Plante TG; Anaissie EJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):12-20. PubMed ID: 19135938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect.
    Alyea E; Weller E; Schlossman R; Canning C; Mauch P; Ng A; Fisher D; Gribben J; Freeman A; Parikh B; Richardson P; Soiffer R; Ritz J; Anderson KC
    Bone Marrow Transplant; 2003 Dec; 32(12):1145-51. PubMed ID: 14647268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amifostine feasibility and efficacy in autologous stem cell transplantation for multiple myeloma.
    Stocchi R; Damiani D; Masolini P; Michelutti A; Baccarani M; Tosi P; Fanin R
    Haematologica; 2004 Apr; 89(4):ELT02. PubMed ID: 15075115
    [No Abstract]   [Full Text] [Related]  

  • 8. Splenic rupture following administration of pegfilgrastim in a patient with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Kuendgen A; Fenk R; Bruns I; Dommach M; Schutte A; Engers R; Hünerlitürkoglu A; Haas R; Kobbe G
    Bone Marrow Transplant; 2006 Jul; 38(1):69-70. PubMed ID: 16715114
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy].
    Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular remission of multiple myeloma with cytoreductive autografting followed by a dose-reduced allograft.
    Fujikawa K; Nakaseko C; Cho R; Abe D; Oda K; Tanaka H; Ohwada C; Ozawa S; Takeuchi M; Sakaida E; Shimizu N; Naito M; Nishimura M; Saito Y
    Bone Marrow Transplant; 2007 Nov; 40(10):997-9. PubMed ID: 17724437
    [No Abstract]   [Full Text] [Related]  

  • 12. Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma.
    Tapprich C; Fenk R; Schneider P; Bernhardt A; Haas R; Kobbe G
    Bone Marrow Transplant; 2003 Sep; 32(6):629-31. PubMed ID: 12953137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophagocytic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma; successful treatment with high-dose intravenous immunoglobulin.
    Ostronoff M; Ostronoff F; Coutinho M; Calixto R; Souto Maior AP; Sucupira A; Florencio R; Tagliari C
    Bone Marrow Transplant; 2006 Apr; 37(8):797-8. PubMed ID: 16518425
    [No Abstract]   [Full Text] [Related]  

  • 14. Newly diagnosed multiple myeloma: allograft or autograft?
    Gupta D; Kumar L
    Natl Med J India; 2007; 20(6):300-1. PubMed ID: 18335797
    [No Abstract]   [Full Text] [Related]  

  • 15. Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicity.
    Ando T; Yujiri T; Tominaga T; Shinya S; Takahashi T; Nomiyama J; Seguchi M; Matsubara A; Fujii Y; Tanizawa Y
    Eur J Haematol; 2005 Feb; 74(2):175-9. PubMed ID: 15654912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
    Haas PS; Bauchmüller K; Kühnemund A; Finke J; Ihorst G; Engelhardt M
    Ann Hematol; 2006 Mar; 85(3):191-3. PubMed ID: 16365747
    [No Abstract]   [Full Text] [Related]  

  • 18. Symptom management and successful outpatient transplantation for patients with multiple myeloma.
    Coleman EA; Coon SK; Mattox SG; O'Sullivan P
    Cancer Nurs; 2002 Dec; 25(6):452-60. PubMed ID: 12464837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation.
    Sherman AC; Simonton S; Latif U; Spohn R; Tricot G
    Bone Marrow Transplant; 2004 May; 33(9):955-62. PubMed ID: 15034542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune responses in multiple myeloma patients with treatment-induced cytopenia early after high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
    Wendelbo Ø; Nesthus I; Sjo M; Ernst P; Bruserud Ø
    Leuk Res; 2004 May; 28(5):461-8. PubMed ID: 15068899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.